Results 231 to 240 of about 69,334 (300)

Pygenic acid A, a small-molecule PD-1/SHP-2 inhibitor, enhances efficacy of therapeutic melanoma vaccines and prophylactic influenza vaccines. [PDF]

Virol Sin
Yan Y, Li Y, Mei W, Li Y, Wang Q, Li H, Lu L, Jiang S.   +7 more
europepmc   +1 more source

Development of a Self-Adjuvanting Influenza Peptide-Glycolipid Conjugate Inducing CD8⁺ T-Cell Immunity. [PDF]

Chembiochem
Kikuchi S, Ogura H, Matsumaru T, Ishido S, Fujimoto Y.   +4 more
europepmc   +1 more source

Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvant. [PDF]

mSphere
Riley DV, Baracco L, Das S, Tenaglia BM, Speed S, Dillen C, Hayes J, Del Veliz S, Nijhuis H, Le Sage V, Despres HW, Coughlan L, Sun W, Frieman MB, Ernst RK.   +14 more
europepmc   +1 more source

Identification of Mannose-Capped-Arabinomannan 101-mer as a Potential Influenza Virus Vaccine Adjuvant. [PDF]

Adv Sci (Weinh)
Zhang YF, Xu R, Luo J, Ma Y, Xiao G, Liu Y.   +5 more
europepmc   +1 more source

Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity. [PDF]

Angew Chem Int Ed Engl
Dang S, Sun Y, Chen L, Dong Y, Han Z, Hou J, Wang X, Kang Z, Liu Z, Wang Z, Li Q, Ren J, Li F.   +12 more
europepmc   +1 more source

Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer. [PDF]

BMC Cancer
Ihlamur M, Demi̇rci̇oğlu A, Zorba AP, Abamor EŞ, Bağırova M, Allahverdi̇yev A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lithium as an immunologic adjuvant

Medical Hypotheses, 1980
Lithium, an adenylate cyclase inhibitor, stimulates a variety of in vitro indices of immune function, including proliferation of lymphocytes in response to mitogens, rosette formation by T-cells and phagocytosis by macrophages. Lithium enhances these immunologic responses at concentrations comparable to those achieved in patients receiving lithium for ...
L, Shenkman, W, Borkowsky, B, Shopsin
openaire   +2 more sources

DDA as an immunological adjuvant

Research in Immunology, 1992
As compared to other adjuvants, DDA is a moderate or strong adjuvant for humoral responses and a strong adjuvant for CMI, especially DTH responses, against different types of antigens and in both laboratory animals and larger animals. DDA can collaborate with other immunomodulating compounds resulting in further enhanced responses.
L A, Hilgers, H, Snippe
openaire   +2 more sources

Cytokines as immunological adjuvants

Vaccine, 1992
Various cytokines have been shown to be effective immunological adjuvants in a variety of model systems, enhancing protection induced by viral, bacterial and parasitic vaccines, and increasing parameters of immunity in tumour immunization models and in clinical trials.
A W, Heath, J H, Playfair
openaire   +2 more sources

Comparison of immunological adjuvants

APMIS, 2019
In this study, several innate immunological adjuvants and related compounds were compared with respect to complement activation in serum and induction of cytokine release in whole blood samples using immunoassays. As found, simple lipids had no effect on the complement system or on cytokine release, whereas lipopolysaccharides induced prominent release
Nicole H, Trier, Esin, Güven, Kristin, Skogstrand, Evaldas, Ciplys, Rimantas, Slibinskas, Gunnar, Houen   +5 more
openaire   +2 more sources